About AVT
Browse Articles
Authors
Customer Services

Current Issue

Displaying 11 results:

Case report

A case study of chewed Truvada® for PrEP maintaining protective drug levels as measured by a novel urine tenofovir assay

Linden Lalley-Chareczko, Devon Clark, Athena F Zuppa, Ganesh Moorthy, Caitlin Conyngham, Karam Mounzer, Helen Koenig

Antiviral Therapy 2017; 22:639-641


Short communication

Topical treatment of herpes simplex virus infection with enzymatically created siRNA swarm

Henrik Paavilainen, Jenni Lehtinen, Alesia Romanovskaya, Michaela Nygårdas, Dennis H Bamford, Minna M Poranen, Veijo Hukkanen

Antiviral Therapy 2017; 22:631-637


Short communication

Prevalence of rilpivirine resistance in people starting antiretroviral treatment in Argentina

Emiliano Bissio, Maria G Barbás, Silvia Kademián, Maria B Bouzas, Horacio Salomón, Analia Cudolá, Silvina Fernández Giuliano, Carlos Falistocco

Antiviral Therapy 2017; 22:625-629


Short communication

Telaprevir-containing triple therapy in acute HCV coinfection: The CHAT Study

Christoph Boesecke, Gurmit K Jagjit Singh, Stefan H-A Scholten, Thomas Lutz, Axel Baumgarten, Stephan M Schneeweiss, Andreas Trein, Michael Rausch, Patrick Ingiliz, Jürgen K Rockstroh, Mark Nelson, the CHAT study group

Antiviral Therapy 2017; 22:619-623


Short communication

In vitro susceptibility of geographically and temporally distinct Zika viruses to favipiravir and ribavirin

Mariana Baz, Nathalie Goyette, Bryan D Griffin, Gary P Kobinger, Guy Boivin

Antiviral Therapy 2017; 22:613-618


Original article

Geniposide demonstrates anti-inflammatory and antiviral activity against pandemic A/Jiangsu/1/2009 (H1N1) influenza virus infection in vitro and in vivo

Yunshi Zhang, Jing Yao, Xian Qi, Xing Liu, Xieqin Lu, Ganzhu Feng

Antiviral Therapy 2017; 22:599-611


Original article

In vitro selection of resistance to sofosbuvir in HCV replicons of genotype-1 to -6

Simin Xu, Brian Doehle, Sonal Rajyaguru, Bin Han, Ona Barauskas, Joy Feng, Jason Perry, Hadas Dvory-Sobol, Evguenia S Svarovskaia, Michael D Miller, Hongmei Mo

Antiviral Therapy 2017; 22:587-597


Original article

Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes

Priya Bhagwat, Ighovwerha Ofotokun, Grace A McComsey, Todd T Brown, Carlee Moser, Catherine A Sugar, Judith S Currier

Antiviral Therapy 2017; 22:577-586


Original article

Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C

Isabella Esposito, Laura Benítez-Gutiérrez, Ana Treviño, Ana Arias, Maria Jesus Citores, Silvia Requena, Vicente Soriano, Valentín Cuervas-Mons, Carmen de Mendoza

Antiviral Therapy 2017; 22:571-575


Original article

Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up

Fatih Karakaya, Sevil Özer, Çağdaş Kalkan, E Ali Tüzün, Aysun Çalışkan, Onur Keskin, Gökhan Kabaçam, Senem Karatayli, Ersin Karatayli, A Mithat Bozdayi, Ramazan Idilman, Cihan Yurdaydin

Antiviral Therapy 2017; 22:559-570


Page:
Copyright © Nucleus Global 2017. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.